DK0979235T3 - Isoleret nukleinsyremolekyle, der koder for tumorafstödende antigenprecursors MAGE-C1 og MAGE-C2, og anvendelser deraf - Google Patents

Isoleret nukleinsyremolekyle, der koder for tumorafstödende antigenprecursors MAGE-C1 og MAGE-C2, og anvendelser deraf

Info

Publication number
DK0979235T3
DK0979235T3 DK98918810T DK98918810T DK0979235T3 DK 0979235 T3 DK0979235 T3 DK 0979235T3 DK 98918810 T DK98918810 T DK 98918810T DK 98918810 T DK98918810 T DK 98918810T DK 0979235 T3 DK0979235 T3 DK 0979235T3
Authority
DK
Denmark
Prior art keywords
mage
nucleic acid
isolated nucleic
repellent
acid molecule
Prior art date
Application number
DK98918810T
Other languages
English (en)
Inventor
Thierry Boon-Falleur
Sophie Lucas
Smet Charles De
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of DK0979235T3 publication Critical patent/DK0979235T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98918810T 1997-04-25 1998-04-24 Isoleret nukleinsyremolekyle, der koder for tumorafstödende antigenprecursors MAGE-C1 og MAGE-C2, og anvendelser deraf DK0979235T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/845,528 US6027924A (en) 1997-04-25 1997-04-25 Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof

Publications (1)

Publication Number Publication Date
DK0979235T3 true DK0979235T3 (da) 2006-04-10

Family

ID=25295436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98918810T DK0979235T3 (da) 1997-04-25 1998-04-24 Isoleret nukleinsyremolekyle, der koder for tumorafstödende antigenprecursors MAGE-C1 og MAGE-C2, og anvendelser deraf

Country Status (11)

Country Link
US (4) US6027924A (da)
EP (1) EP0979235B1 (da)
JP (1) JP3915076B2 (da)
AT (1) ATE313551T1 (da)
AU (1) AU739680B2 (da)
DE (1) DE69832875T2 (da)
DK (1) DK0979235T3 (da)
ES (1) ES2251080T3 (da)
PT (1) PT979235E (da)
WO (1) WO1998049184A1 (da)
ZA (1) ZA983488B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1659179T3 (da) 1998-02-05 2011-10-10 Glaxosmithkline Biolog Sa Tumor-associerede antigenderivater fra MAGE-familien og nucleinsyresekvenser kodende for dem anvendt til fremstilling af fusionsproteiner og sammensætninger til vaccination
US6297364B1 (en) * 1998-04-17 2001-10-02 Ludwig Institute For Cancer Research Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
WO2004029071A2 (en) * 2002-09-27 2004-04-08 Ludwig Institute For Cancer Research Mage-c2 antigenic peptides and uses thereof
US6903287B2 (en) * 2003-04-14 2005-06-07 Agilent Technologies, Inc. Liquid metal optical relay
DE102005041616B4 (de) * 2005-09-01 2011-03-17 Johannes-Gutenberg-Universität Mainz Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen
GB0721686D0 (en) * 2007-11-05 2007-12-12 Medinnova As Polypeptides
GB201520539D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520541D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889806A (en) * 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US6235525B1 (en) * 1991-05-23 2001-05-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
ATE342730T1 (de) * 1992-08-07 2006-11-15 Pharmexa Inc Hla bindepeptide und ihre verwendungen
US5462871A (en) * 1992-08-31 1995-10-31 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode MAGE derived nonapeptides
US5405940A (en) * 1992-08-31 1995-04-11 Ludwig Institute For Cancer Research Isolated nonapeptides derived from MAGE genes and uses thereof
US5487974A (en) * 1992-12-22 1996-01-30 Ludwig Institute For Cancer-Research Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells
CA2168582A1 (en) * 1993-08-06 1995-02-16 John D. Fikes Cloning and characterization of the complete mage-1 gene
US5512444A (en) * 1994-03-01 1996-04-30 Ludwig Institute For Cancer Research Method for determining bladder tumors by assaying for MAGE-1,2,3 or 4
EP0871765B1 (en) * 1994-03-01 2001-11-28 Ludwig Institute For Cancer Research Determination of cancerous conditions by mage gene expression
US5554506A (en) * 1994-03-24 1996-09-10 Ludwig Institute For Cancer Research Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
US5554724A (en) * 1994-03-24 1996-09-10 University Of Leiden Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof

Also Published As

Publication number Publication date
DE69832875T2 (de) 2006-08-24
US5997872A (en) 1999-12-07
DE69832875D1 (de) 2006-01-26
ATE313551T1 (de) 2006-01-15
PT979235E (pt) 2006-05-31
JP2002503096A (ja) 2002-01-29
ZA983488B (en) 1999-01-19
WO1998049184A1 (en) 1998-11-05
US6475783B1 (en) 2002-11-05
AU7166598A (en) 1998-11-24
JP3915076B2 (ja) 2007-05-16
US6027924A (en) 2000-02-22
US20030170256A1 (en) 2003-09-11
US7022819B2 (en) 2006-04-04
EP0979235B1 (en) 2005-12-21
EP0979235A1 (en) 2000-02-16
ES2251080T3 (es) 2006-04-16
EP0979235A4 (en) 2003-01-15
AU739680B2 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
DK0595838T3 (da) Tumorafstödningsantigenprecursorer, tumorafstödningsantigener og anvendelser deraf
UA106036C2 (uk) Анти-мезотелінове антитіло та його застосування
EP1067182A8 (en) Secretory protein or membrane protein
ZA958039B (en) Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
NO953699D0 (no) Isolerte nukleinsyremolekyler som koder for tumor-rejeksjonsforlöperen MAGE-3, samt anvendelser derav
WO1996040039A3 (en) Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
FI956019A0 (fi) Eristettyjä peptidejä, jotka muodostavat komplekseja MHC-molekyyli HLA-C-klooni-10:n kanssa, ja niiden käyttö
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
ATE394484T1 (de) Smad 6 und dessen anwendungen
WO2001047959A3 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
DK0979235T3 (da) Isoleret nukleinsyremolekyle, der koder for tumorafstödende antigenprecursors MAGE-C1 og MAGE-C2, og anvendelser deraf
WO2003074073A3 (fr) Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications.
DE69626789D1 (de) Isolierte und verkürzte nukleinsäuremoleküle kodierend für gage-tumorabstossungsantigen
DK1536006T3 (da) Cancerantigener og anvendelse deraf
DE60042497D1 (de) Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
BR0011469A (pt) Gm-csf equina
UY26170A1 (es) Antigeno (c42) asociados a tumores
NZ512332A (en) Potassium channel interactors and uses therefor
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
CY1115966T1 (el) Ανταγωνιστικα αντισωματα anti-htnfsf13b ανθρωπου